Zymergen Inc. Asset Turnover Ratio (ZY), as of second quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Zymergen Inc.  (NASDAQ: ZY)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Zymergen Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Zymergen's asset turnover ratio has remained unchanged compare to previous quarter at 0.03 in the second quarter (Jun 30 2022)

Within sector 25 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2022, to 2922, from total ranking in the first quarter 2022 at 3995.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZY Asset Turnover Ratio (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter
Y / Y Asset Change -54.43 % 108.24 % 77.87 % - -
Y / Y Revenue Change -55.26 % 28.27 % -48.54 % 27.24 % 384.13 %
Asset Turnover Ratio (TTM) 0.03 0.03 0.03 0.04 0.06
ZY's Total Ranking # 2922 # 3995 # 4141 # 0 # 0
Seq. Asset Change -30.13 % -9.42 % -16.73 % -13.52 % 219.25 %
Seq. Revenue Change -45.02 % 57.65 % -25.55 % -30.66 % 57.62 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 26
Healthcare Sector # 442
Overall Market # 2922

Asset Turnover Ratio Statistics
High Average Low
4.93 4.39 3.63
(Jun 30 2022)   (Mar 31 2021)




ZY Company Profile • Back to ZY Efficiency Comparisons • Compare ZY Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2022 Assets at quarter ending Jun 30 2022
Isoplexis Corporation  0.12 $ 18.495  Millions$ 154.105  Millions
Cyclo Therapeutics Inc   0.12 $ 1.726  Millions$ 14.596  Millions
Invitae Corporation  0.12 $ 500.829  Millions$ 4,262.224  Millions
Imagenebio Inc   0.12 $ 27.728  Millions$ 237.129  Millions
Zai Lab Limited  0.12 $ 182.174  Millions$ 1,564.432  Millions
Barinthus Biotherapeutics Plc  0.12 $ 32.099  Millions$ 277.116  Millions
Somalogic Inc   0.11 $ 80.110  Millions$ 705.974  Millions
Kineta Inc   0.11 $ 5.078  Millions$ 44.945  Millions
Sqz Biotechnologies Company  0.11 $ 23.189  Millions$ 212.833  Millions
Apellis Pharmaceuticals Inc   0.11 $ 96.643  Millions$ 888.951  Millions
Universal Biosensors Inc   0.11 $ 5.470  Millions$ 50.534  Millions
Arcturus Therapeutics Holdings Inc   0.11 $ 40.568  Millions$ 376.588  Millions
Astrazeneca Plc  0.11 $ 10,771.000  Millions$ 100,947.000  Millions
Cvrx inc   0.11 $ 16.160  Millions$ 153.174  Millions
Acutus Medical Inc   0.10 $ 16.720  Millions$ 159.297  Millions
Chinook Therapeutics Inc   0.10 $ 54.355  Millions$ 519.900  Millions
Bridgebio Pharma Inc   0.10 $ 90.670  Millions$ 867.425  Millions
Yubo International Biotech Limited  0.10 $ 0.454  Millions$ 4.365  Millions
Vivos Therapeutics Inc   0.10 $ 3.331  Millions$ 32.161  Millions
Novan Inc   0.10 $ 9.478  Millions$ 92.322  Millions
Novartis Ag  0.10 $ 12,781.000  Millions$ 125,988.250  Millions
Vyne Therapeutics Inc   0.10 $ 6.682  Millions$ 66.968  Millions
C4 Therapeutics Inc   0.10 $ 50.066  Millions$ 505.659  Millions
Intelgenx Technologies Corp   0.10 $ 1.722  Millions$ 17.692  Millions
Kymera Therapeutics Inc   0.10 $ 56.747  Millions$ 583.710  Millions
Polarityte Inc   0.09 $ 2.972  Millions$ 32.628  Millions
Lineage Cell Therapeutics Inc   0.09 $ 13.228  Millions$ 146.550  Millions
Eiger Biopharmaceuticals Inc   0.09 $ 13.163  Millions$ 145.925  Millions
Nektar Therapeutics  0.09 $ 96.337  Millions$ 1,070.134  Millions
Aravive Inc   0.09 $ 6.104  Millions$ 68.586  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.